Pfizer nears deal to acquire Medivation for close to $14 billion

0 Comments 3 view(s)

(Reuters) – Pfizer Inc is in advanced talks to acquire U.S. cancer drug company Medivation Inc for close to $14 billion, as it seeks to boost its oncology portfolio, people familiar with the matter said on Sunday.

Powered by WPeMatico